{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:44:53Z","timestamp":1788396293015,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"SNUBH Research Fund","award":["14-2018-019"],"award-info":[{"award-number":["14-2018-019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10633-020-09772-1","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T06:02:31Z","timestamp":1590732151000},"page":"313-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A case of melanoma-associated retinopathy with autoantibodies against TRPM1"],"prefix":"10.1007","volume":"141","author":[{"given":"Min Seok","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Kyoung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Jin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Okado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Joon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4266-1491","authenticated-orcid":false,"given":"Kwangsic","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"issue":"4","key":"9772_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/practneurol-2011-000061","volume":"11","author":"R Dobson","year":"2011","unstructured":"Dobson R, Lawden M (2011) Melanoma associated retinopathy and how to understand the electroretinogram. Pract Neurol 11(4):234\u2013239. https:\/\/doi.org\/10.1136\/practneurol-2011-000061","journal-title":"Pract Neurol"},{"issue":"1","key":"9772_CR2","first-page":"91","volume":"34","author":"AH Milam","year":"1993","unstructured":"Milam AH, Saari JC, Jacobson SG, Lubinski WP, Feun LG, Alexander KR (1993) Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 34(1):91\u2013100","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"9772_CR3","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1097\/IAE.0000000000002329","volume":"39","author":"S Ueno","year":"2019","unstructured":"Ueno S, Inooka D, Nakanishi A, Okado S, Yasuda S, Kominami T, Sayo A, Morimoto T, Kondo M, Katagiri S, Hayashi T, Terasaki H (2019) Clinical course of paraneoplastic retinopathy with Anti-Trpm1 autoantibody in Japanese cohort. Retina 39(12):2410\u20132418. https:\/\/doi.org\/10.1097\/IAE.0000000000002329","journal-title":"Retina"},{"issue":"5","key":"9772_CR4","doi-asserted-by":"publisher","first-page":"e19911","DOI":"10.1371\/journal.pone.0019911","volume":"6","author":"M Kondo","year":"2011","unstructured":"Kondo M, Sanuki R, Ueno S, Nishizawa Y, Hashimoto N, Ohguro H, Yamamoto S, Machida S, Terasaki H, Adamus G, Furukawa T (2011) Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS ONE 6(5):e19911. https:\/\/doi.org\/10.1371\/journal.pone.0019911","journal-title":"PLoS ONE"},{"issue":"5","key":"9772_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/CMR.0000000000000375","volume":"27","author":"T Tomizuka","year":"2017","unstructured":"Tomizuka T, Namikawa K, Higashi T (2017) Characteristics of melanoma in Japan: a nationwide registry analysis 2011\u20132013. Melanoma Res 27(5):492\u2013497. https:\/\/doi.org\/10.1097\/CMR.0000000000000375","journal-title":"Melanoma Res"},{"issue":"3","key":"9772_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4143\/crt.2017.166","volume":"50","author":"CM Oh","year":"2018","unstructured":"Oh CM, Cho H, Won YJ, Kong HJ, Roh YH, Jeong KH, Jung KW (2018) Nationwide trends in the incidence of melanoma and non-melanoma skin cancers from 1999 to 2014 in South Korea. Cancer Res Treat 50(3):729\u2013737. https:\/\/doi.org\/10.4143\/crt.2017.166","journal-title":"Cancer Res Treat"},{"issue":"3","key":"9772_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00041327-200109000-00004","volume":"21","author":"JL Keltner","year":"2001","unstructured":"Keltner JL, Thirkill CE, Yip PT (2001) Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 21(3):173\u2013187","journal-title":"J Neuroophthalmol"},{"issue":"11","key":"9772_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamaophthalmol.2017.3500","volume":"135","author":"JJ Tian","year":"2017","unstructured":"Tian JJ, Coupland S, Karanjia R, Sadun AA (2017) Melanoma-associated retinopathy 28 years after diagnosis. JAMA Ophthalmol 135(11):1276\u20131277. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.3500","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"9772_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1365-2133.2005.06480.x","volume":"152","author":"G Ladewig","year":"2005","unstructured":"Ladewig G, Reinhold U, Thirkill CE, Kerber A, Tilgen W, Pfohler C (2005) Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I\u2013IV. Br J Dermatol 152(5):931\u2013938. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06480.x","journal-title":"Br J Dermatol"},{"issue":"12","key":"9772_CR10","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1001\/archophthalmol.2009.311","volume":"127","author":"Y Lu","year":"2009","unstructured":"Lu Y, Jia L, He S, Hurley MC, Leys MJ, Jayasundera T, Heckenlively JR (2009) Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol 127(12):1572\u20131580. https:\/\/doi.org\/10.1001\/archophthalmol.2009.311","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"9772_CR11","first-page":"477","volume":"33","author":"KR Alexander","year":"1992","unstructured":"Alexander KR, Fishman GA, Peachey NS, Marchese AL, Tso MO (1992) \u2018On\u2019 response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 33(3):477\u2013483","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"9772_CR12","first-page":"262","volume":"41","author":"B Lei","year":"2000","unstructured":"Lei B, Bush RA, Milam AH, Sieving PA (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41(1):262\u2013266","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"9772_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11940-009-0057-x","volume":"12","author":"SF Powell","year":"2010","unstructured":"Powell SF, Dudek AZ (2010) Treatment of melanoma-associated retinopathy. Curr Treat Options Neurol 12(1):54\u201363. https:\/\/doi.org\/10.1007\/s11940-009-0057-x","journal-title":"Curr Treat Options Neurol"},{"key":"9772_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/icb.0000000000000882","author":"KF Elwood","year":"2019","unstructured":"Elwood KF, Pulido JS, Ghafoori SD, Harper CA, Wong RW (2019) Choroidal neovascularization and chorioretinal atrophy in a patient with melanoma-associated retinopathy after ipilimumab\/nivolumab combination therapy. Retin Cases Brief Rep. https:\/\/doi.org\/10.1097\/icb.0000000000000882","journal-title":"Retin Cases Brief Rep"},{"issue":"4","key":"9772_CR15","first-page":"1189","volume":"43","author":"KR Alexander","year":"2002","unstructured":"Alexander KR, Barnes CS, Fishman GA, Milam AH (2002) Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 43(4):1189\u20131197","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-020-09772-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-020-09772-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-020-09772-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T23:27:19Z","timestamp":1622244439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-020-09772-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9772"],"URL":"https:\/\/doi.org\/10.1007\/s10633-020-09772-1","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"18 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with a financial interest (such as honoraria, educational grants, participation in speaker\u2019s bureaus, membership, employment, consultancies, stock ownership or other equity interest, and expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationship, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"All applicable international, national and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}},{"value":"Informed consent was obtained from the participant included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}